  """
  Data for NCT00002495, SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease.

  NCT Number: NCT00002495
  Study Title: SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease
  Study URL: https://clinicaltrials.gov/study/NCT00002495
  Acronym:
  Study Status: COMPLETED
  Brief Summary: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells.

  PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without doxorubicin and vinblastine in treating patients with stage I or stage II Hodgkin's disease.
  Study Results: NO
  Conditions: Lymphoma
  Interventions: DRUG: doxorubicin hydrochloride|DRUG: vinblastine|RADIATION: standard subtotal nodal irradiation
  Primary Outcome Measures: progression-free survival, every 3 months while on protocol treatment, then every 6 months for 2 years, then annually thereafter|overall survival, every 3 months while on protocol treatment, then every 6 months for 2 years, then annually thereafter
  Secondary Outcome Measures:
  Other Outcome Measures:
  Sponsor: SWOG Cancer Research Network
  Collaborators: National Cancer Institute (NCI)|Cancer and Leukemia Group B
  Sex: ALL
  Age: CHILD, ADULT, OLDER_ADULT
  Phases: PHASE3
  Enrollment: 348
  Funder Type: NETWORK
  Study Type: INTERVENTIONAL
  Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
  Other IDs: CDR0000077691|U10CA032102|SWOG-9133|CLB-9391
  Start Date: 1992-09
  Primary Completion Date: 2000-11
  Completion Date: 2014-04
  First Posted: 2004-07-19
  Results First Posted:
  Last Update Posted: 2017-02-20
  Locations: University of California San Diego Cancer Center, La Jolla, California, 92093-0658, United States|CCOP - Christiana Care Health Services, Wilmington, Delaware, 19899, United States|Walter Reed Army Medical Center, Washington, District of Columbia, 20307-5000, United States|CCOP - Mount Sinai Medical Center, Miami Beach, Florida, 33140, United States|University of Chicago Cancer Research Center, Chicago, Illinois, 60637, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States|University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, 01655, United States|University of Minnesota Cancer Center, Minneapolis, Minnesota, 55455, United States|Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, 65203, United States|Barnes-Jewish Hospital, Saint Louis, Missouri, 63110, United States|CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, 89106, United States|Norris Cotton Cancer Center, Lebanon, New Hampshire, 03756, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263-0001, United States|CCOP - North Shore University Hospital, Manhasset, New York, 11030, United States|Mount Sinai Medical Center, NY, New York, New York, 10029, United States|State University of New York - Upstate Medical University, Syracuse, New York, 13210, United States|CCOP - Southeast Cancer Control Consortium, Winston-Salem, North Carolina, 27104-4241, United States|Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, 27157-1082, United States|Rhode Island Hospital, Providence, Rhode Island, 02903, United States|University of Tennessee, Memphis Cancer Center, Memphis, Tennessee, 38163, United States|Vermont Cancer Center, Burlington, Vermont, 05401-3498, United States|MBCCOP - Massey Cancer Center, Richmond, Virginia, 23298-0037, United States
  Study Documents:
  """

NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00002495,SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease,https://clinicaltrials.gov/study/NCT00002495,,COMPLETED,"RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells.

PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without doxorubicin and vinblastine in treating patients with stage I or stage II Hodgkin's disease.",NO,Lymphoma,DRUG: doxorubicin hydrochloride|DRUG: vinblastine|RADIATION: standard subtotal nodal irradiation,"progression-free survival, every 3 months while on protocol treatment, then every 6 months for 2 years, then annually thereafter|overall survival, every 3 months while on protocol treatment, then every 6 months for 2 years, then annually thereafter",,,SWOG Cancer Research Network,National Cancer Institute (NCI)|Cancer and Leukemia Group B,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,348,NETWORK,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,CDR0000077691|U10CA032102|SWOG-9133|CLB-9391,1992-09,2000-11,2014-04,2004-07-19,,2017-02-20,"University of California San Diego Cancer Center, La Jolla, California, 92093-0658, United States|CCOP - Christiana Care Health Services, Wilmington, Delaware, 19899, United States|Walter Reed Army Medical Center, Washington, District of Columbia, 20307-5000, United States|CCOP - Mount Sinai Medical Center, Miami Beach, Florida, 33140, United States|University of Chicago Cancer Research Center, Chicago, Illinois, 60637, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States|University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, 01655, United States|University of Minnesota Cancer Center, Minneapolis, Minnesota, 55455, United States|Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, 65203, United States|Barnes-Jewish Hospital, Saint Louis, Missouri, 63110, United States|CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, 89106, United States|Norris Cotton Cancer Center, Lebanon, New Hampshire, 03756, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263-0001, United States|CCOP - North Shore University Hospital, Manhasset, New York, 11030, United States|Mount Sinai Medical Center, NY, New York, New York, 10029, United States|State University of New York - Upstate Medical University, Syracuse, New York, 13210, United States|CCOP - Southeast Cancer Control Consortium, Winston-Salem, North Carolina, 27104-4241, United States|Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, 27157-1082, United States|Rhode Island Hospital, Providence, Rhode Island, 02903, United States|University of Tennessee, Memphis Cancer Center, Memphis, Tennessee, 38163, United States|Vermont Cancer Center, Burlington, Vermont, 05401-3498, United States|MBCCOP - Massey Cancer Center, Richmond, Virginia, 23298-0037, United States",

